«Panuveitis

Below is an extended Panuveitis patents listing. Click here to return to the Panuveitis main in depth entry.

Patents :
US Patent No.	Title
7339065	Design and synthesis of optimized ligands for PPAR
5597567	Blocking cell adhesion molecules and treating animals with ocular inflammation
5773019	Implantable controlled release device to deliver drugs directly to an internal portion of the body
5902790	Pharmaceutical angiostatic dipeptide compositions and method of use thereof
6001386	Implantable controlled release device to deliver drugs directly to an internal portion of the body
6080737	Uveitis remedy
6096713	Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
6254860	Ocular treatment using cyclosporin-A derivatives
6316465	Ophthalmic uses of PPARgamma agonists and PPARgamma antagonists
6350442	Ocular treatment using cyclosporin-A derivatives
6369098	Dithiolane derivatives
6664287	Antioxidants
6693077	Keratinocyte growth factor-2
6726918	Methods for treating inflammation-mediated conditions of the eye
7229961	Compositions and methods for enhancing drug delivery across and into ocular tissues
7232667	Keratinocyte growth factor-2 polynucleotides
7232828	PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
4649047	Ophthalmic treatment by topical administration of cyclosporin

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.